Sumatriptan, a selective serotonin receptor agonist, acts on 5-HT1B/1D receptors in cerebral blood vessels and trigeminal neurons to constrict cranial vasculature and inhibit neuropeptide release. When used for cluster headaches, it rapidly reduces pain and associated symptoms by targeting the underlying neurogenic inflammation and vascular dysregulation characteristic of these severe headaches.